From: Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy
Variables
BCR-free survival
Exp (B)
95% CI
P
Pathological stage
4.11
1.02–8.08
0.001
Lymph node metastasis
3.13
0.81–4.20
0.03
Angiolymphatic invasion
4.62
1.13–9.09
miR-126 expression
3.68
0.99–6.83
0.01